Cargando…
Agomelatine Softens Depressive-Like Behavior through the Regulation of Autophagy and Apoptosis
Depression is a common and disabling mental disorder with high recurrence rate. Searching for more effective treatments for depression is a long-standing primary objective in neuroscience. Agomelatine (AGO) was reported as an antidepressant with unique pharmacological effects. However, its effects a...
Autores principales: | Chen, Fengpei, Chen, Shijia, Liu, Jie, Amin, Nashwa, Jin, Weidong, Fang, Marong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994102/ https://www.ncbi.nlm.nih.gov/pubmed/33791372 http://dx.doi.org/10.1155/2021/6664591 |
Ejemplares similares
-
Hypoxia Inducible Factor-1α Attenuates Ischemic Brain Damage by Modulating Inflammatory Response and Glial Activity
por: Amin, Nashwa, et al.
Publicado: (2021) -
Inhibition of Autophagy in Microglia Alters Depressive-Like Behavior via BDNF Pathway in Postpartum Depression
por: Tan, Xiaoning, et al.
Publicado: (2018) -
Agomelatine for postpartum depression and
breastfeeding
por: Xiao, Le
Publicado: (2021) -
The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022) -
SIRT1 Protects Against Apoptosis by Promoting Autophagy in the Oxygen Glucose Deprivation/Reperfusion-Induced Injury
por: Ren, Qiannan, et al.
Publicado: (2019)